I think the biggest difference with IMU and RAC that can't be discounted is the fact that RAC is a one trick pony, and a very old trick that RAC seems to think Oncologists would pay $60K per treatment for it's use. IMU has multiple irons in the fire all new treatments moving into Immunotherapy and away from harmful Chemotherapies. I do wish RAC success with it's trials because every step forward in cancer treatment is a win, but success with old school reformulated drugs is a very hard road to walk. As can be seen with the length of time it has taken RAC to get to PH1 from 2016 and this was a drug that had an approval of sorts in the nineties.
IMU Price at posting:
3.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)